March 2024 FDA Recall Infumorph 200 by Hikma Pharmaceuticals Usa Inc.
D-0392-2024 - The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.

This Class II drug recall was voluntarily initiated by Hikma Pharmaceuticals Usa Inc. on March 12, 2024 for the product Infumorph 200. The FDA reported the reason for recall as the filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0392-2024

Reason for Recall
The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.
Initiated
03-12-2024
Reported
03-27-2024
Quantity
22,644 ampuls

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Hikma Pharmaceuticals USA Inc.
Nationwide within the United States
Infumorph (Preservative-free Morphine Sulfate Sterile Solution), 20 mL ampul, Rx only, Manufactured by Hikma Berkeley Heights, NJ 07922, NDC 0641-6039-01

Batch or Lot Expiration Information

Lot# : 052001, 052003, Exp. Date 11/2024; 023012, 023014, Exp. Date 08/2024

Affected Packages Involved in this Recall